133 related articles for article (PubMed ID: 11943324)
21. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
22. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.
Kim YS; Kim MN; Lee KE; Hong JY; Oh MS; Kim SY; Kim KW; Sohn MH
Clin Exp Immunol; 2018 May; 192(2):151-164. PubMed ID: 29363753
[TBL] [Abstract][Full Text] [Related]
23. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
24. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
[TBL] [Abstract][Full Text] [Related]
25. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72).
Luo W; Van de Velde H; von Hoegen I; Parnes JR; Thielemans K
J Immunol; 1992 Mar; 148(6):1630-4. PubMed ID: 1371783
[TBL] [Abstract][Full Text] [Related]
26. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation.
Castro MA; Nunes RJ; Oliveira MI; Tavares PA; Simões C; Parnes JR; Moreira A; Carmo AM
J Leukoc Biol; 2003 Jan; 73(1):183-90. PubMed ID: 12525577
[TBL] [Abstract][Full Text] [Related]
27. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
28. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
[TBL] [Abstract][Full Text] [Related]
29. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
31. Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions.
Bowen MA; Aruffo A
Transplant Proc; 1999; 31(1-2):795-6. PubMed ID: 10083342
[No Abstract] [Full Text] [Related]
32. Extensive polymorphism in the extracellular domain of the mouse B cell differentiation antigen Lyb-2/CD72.
Robinson WH; Ying H; Miceli MC; Parnes JR
J Immunol; 1992 Aug; 149(3):880-6. PubMed ID: 1634777
[TBL] [Abstract][Full Text] [Related]
33. Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166).
Fujiwara H; Tatsumi K; Kosaka K; Sato Y; Higuchi T; Yoshioka S; Maeda M; Ueda M; Fujii S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3437-43. PubMed ID: 12843199
[TBL] [Abstract][Full Text] [Related]
34. The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system.
Sarrias MR; Grønlund J; Padilla O; Madsen J; Holmskov U; Lozano F
Crit Rev Immunol; 2004; 24(1):1-37. PubMed ID: 14995912
[TBL] [Abstract][Full Text] [Related]
35. Expression and characterization of a novel CD6 ligand in cells derived from joint and epithelial tissues.
Saifullah MK; Fox DA; Sarkar S; Abidi SM; Endres J; Piktel J; Haqqi TM; Singer NG
J Immunol; 2004 Nov; 173(10):6125-33. PubMed ID: 15528349
[TBL] [Abstract][Full Text] [Related]
36. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
37. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins.
Aruffo A; Melnick MB; Linsley PS; Seed B
J Exp Med; 1991 Oct; 174(4):949-52. PubMed ID: 1919444
[TBL] [Abstract][Full Text] [Related]
38. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
39. Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells.
Jamin C; Le Corre R; Pers JO; Dueymes M; Lydyard PM; Youinou P
Int Immunol; 1997 Jul; 9(7):1001-9. PubMed ID: 9237109
[TBL] [Abstract][Full Text] [Related]
40. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
Breuning J; Brown MH
Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
